title: Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance.
authors.affiliation: Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany Department of Endocrinology, Diabetes and Nutrition, Charité Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany rudovich@dife.de.
authors.forename: Natalia
authors.initials: N
authors.lastname: Rudovich
authors.affiliation: Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany Department of Endocrinology, Diabetes and Nutrition, Charité Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany.
authors.forename: Olga
authors.initials: O
authors.lastname: Pivovarova
authors.affiliation: Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany Department of Endocrinology, Diabetes and Nutrition, Charité Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany.
authors.forename: Özlem
authors.initials: Ö
authors.lastname: Gögebakan
authors.affiliation: Thermo Fisher Scientific, B.R.A.H.M.S GmbH (part of Thermo Fisher Scientific), Biotechnology Centre Hennigsdorf, Berlin, Germany.
authors.forename: Andrea
authors.initials: A
authors.lastname: Sparwasser
authors.affiliation: Interdiscplinary Stroke Research, Center for Stroke Research, Charité Universitätsmedizin Berlin, Berlin, Germany.
authors.forename: Wolfram
authors.initials: W
authors.lastname: Doehner
authors.affiliation: Department of Innovative Clinical Trials, University Medical Centre Göttingen, Göttingen, Germany Institute of Diabetes for Older People, University of Bedfordshire, Bedfordshire, U.K.
authors.forename: Stefan D
authors.initials: SD
authors.lastname: Anker
authors.affiliation: Department of Endocrinology, Diabetes and Nutrition, Charité Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany.
authors.forename: Ayman M
authors.initials: AM
authors.lastname: Arafat
authors.affiliation: Thermo Fisher Scientific, B.R.A.H.M.S GmbH (part of Thermo Fisher Scientific), Biotechnology Centre Hennigsdorf, Berlin, Germany Sphingotec GmbH, Biotechnology Centre Hennigsdorf, Berlin, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Bergmann
authors.affiliation: Diabeteszentrum Bad Lauterberg, Bad Lauterberg, Germany.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Nauck
authors.affiliation: Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany Department of Endocrinology, Diabetes and Nutrition, Charité Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany.
authors.forename: Andreas F H
authors.initials: AF
authors.lastname: Pfeiffer
mesh_terms: D061605:Administration, Intravenous; D000368:Aged; D009320:Atrial Natriuretic Factor / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D005260:Female; D005749:Gastric Inhibitory Polypeptide / Q000008:administration & dosage*; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage*; D018149:Glucose Intolerance / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D050177:Overweight / Q000097:blood
chemical_list: D005749:Gastric Inhibitory Polypeptide; D009320:Atrial Natriuretic Factor; D052216:Glucagon-Like Peptide 1